Literature DB >> 11905829

Cytokines and immunodeficiency diseases.

W J Leonard1.   

Abstract

Severe combined immunodeficiency disease (SCID) refers to a spectrum of inherited immunodeficiencies that together represent the most severe forms of primary immunodeficiency in humans. Recent work has shown that many of these diseases, as well as other forms of immunodeficiency, result from defects in cytokine signalling pathways. Such defects can prevent normal development of lymphoid lineages and/or compromise cytokine signalling by these cells. These natural 'experiments' in human genetics have shown the non-redundant role for several cytokines or cytokine signalling molecules. Moreover, a comparison of the phenotypes of humans with SCID to analogous mouse-knockout models has shown not only expected similarities, but also unexpected differences in cytokine signalling between humans and mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11905829     DOI: 10.1038/35105066

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  113 in total

1.  Functional STAT3 deficiency compromises the generation of human T follicular helper cells.

Authors:  Cindy S Ma; Danielle T Avery; Anna Chan; Marcel Batten; Jacinta Bustamante; Stephanie Boisson-Dupuis; Peter D Arkwright; Alexandra Y Kreins; Diana Averbuch; Dan Engelhard; Klaus Magdorf; Sara S Kilic; Yoshiyuki Minegishi; Shigeaki Nonoyama; Martyn A French; Sharon Choo; Joanne M Smart; Jane Peake; Melanie Wong; Paul Gray; Matthew C Cook; David A Fulcher; Jean-Laurent Casanova; Elissa K Deenick; Stuart G Tangye
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

Review 2.  Functions of thymic stromal lymphopoietin in immunity and disease.

Authors:  Yanlu Zhang; Baohua Zhou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 3.  Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond.

Authors:  Alfonso Quintás-Cardama; Hagop Kantarjian; Jorge Cortes; Srdan Verstovsek
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

Review 4.  Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling.

Authors:  Francis Ka-Ming Chan
Journal:  Cytokine       Date:  2007-04-20       Impact factor: 3.861

5.  Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia.

Authors:  Maria Kleppe; Idoya Lahortiga; Tiama El Chaar; Kim De Keersmaecker; Nicole Mentens; Carlos Graux; Katrien Van Roosbroeck; Adolfo A Ferrando; Anton W Langerak; Jules P P Meijerink; François Sigaux; Torsten Haferlach; Iwona Wlodarska; Peter Vandenberghe; Jean Soulier; Jan Cools
Journal:  Nat Genet       Date:  2010-05-16       Impact factor: 38.330

6.  IL-21 mediates suppressive effects via its induction of IL-10.

Authors:  Rosanne Spolski; Hyoung-Pyo Kim; Wei Zhu; David E Levy; Warren J Leonard
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

7.  Human lymphoid development in the absence of common γ-chain receptor signaling.

Authors:  Lisa A Kohn; Christopher S Seet; Jessica Scholes; Felicia Codrea; Rebecca Chan; Sania Zaidi-Merchant; Yuhua Zhu; Satiro De Oliveira; Neena Kapoor; Ami Shah; Hisham Abdel-Azim; Donald B Kohn; Gay M Crooks
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

8.  Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression.

Authors:  Wei Liao; Rosanne Spolski; Peng Li; Ning Du; Erin E West; Min Ren; Suman Mitra; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

Review 9.  Thymic stromal lymphopoietin: a new cytokine in asthma.

Authors:  Yrina Rochman; Warren J Leonard
Journal:  Curr Opin Pharmacol       Date:  2008-04-29       Impact factor: 5.547

10.  IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma.

Authors:  Jennifer Dien Bard; Pascal Gelebart; Mona Anand; Zoulika Zak; Samar A Hegazy; Hesham M Amin; Raymond Lai
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.